Newm-035 Official

: Preclinical trials on mice and ferrets—chosen for their similar dental structures—successfully produced new teeth with normal enamel and root structures and no significant side effects.

: Launched in September 2024 at Kyoto University Hospital. This phase involves 30 healthy adult males aged 30–64 who are missing at least one molar, primarily focusing on safety and dosage. NEWM-035

The drug was developed by , a spinoff from Kyoto University, led by Dr. Katsu Takahashi. : Preclinical trials on mice and ferrets—chosen for

Below is an overview of the development and science behind . TRG-035: The World's First Tooth Regrowth Drug a spinoff from Kyoto University